NCT03769623 - A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease | Biotech Hunter

Enrollment

206

Participants

Timeline

Start Date

June 25, 2019

Primary Completion Date

February 20, 2021

Study Completion Date

April 6, 2021

Conditions

Coronary Artery Disease

Interventions

DEVICE

Biolimus

103 subjects with small coronary artery disease who met the inclusion/exclusion criteria were enrolled, subjects were assigned to the treatment group of Biolimus

DEVICE

Powerline

103 subjects with small coronary artery disease who met the inclusion/exclusion criteria were enrolled, subjects were assigned to the treatment group of Powerline

Trial Locations (1)

110016

General Hospital of Northern Theater Command, Shenyang